ANIP News and Press, ANI Pharmaceuticals Inc. From 11/08/23

2023-11-08 11:59:03 ET ANI Pharmaceuticals, Inc. (ANIP) Q3 2023 Earnings Conference Call November 8, 2023 8:30 AM ET Company Participants Judy DiClemente - Insight Communications IR Nikhil Lalwani - President and CEO Stephen Carey - CFO Conference Call Part...

2023-11-08 06:51:52 ET More on ANI Pharmaceuticals 3 Catalysts Could Drive ANI Pharmaceuticals' PPS Growth Through November 2023 ANI Pharma: Slow And Steady Revenue Generator ANI Pharmaceuticals Q3 2023 Earnings Preview ANI Pharma wins FDA nod for generic Est...

Third Quarter 2023 Financial Results -- Record quarterly net revenues of $131.8 million, representing year-over-year growth of 57.3% ; net income available to common shareholders of $9.5 million and diluted GAAP income per share of $0.45 -- -- R...

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

ANI Pharmaceuticals Inc. (ANIP) is expected to report $0.56 for Q3 2023

2023-11-07 12:38:56 ET More on ANI Pharmaceuticals 3 Catalysts Could Drive ANI Pharmaceuticals' PPS Growth Through November 2023 ANI Pharma: Slow And Steady Revenue Generator ANI Pharmaceuticals, Inc. (ANIP) Q2 2023 Earnings Call Transcript ANI Pharma wins FD...

2023-11-06 10:28:09 ET Summary ANIP's PPS has gained 63.41% YTD and is expected to continue growing. ANIP should record its fifth consecutive quarter beating earnings and revenue consensus. ANIP's Sovuna, a unique version of Hydroxychloroquine sulfate, and a new 1-ml vial vers...

BAUDETTE, Minn., Oct. 30, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will participate at two upcoming healthcare conferences as follows: Trui...

BAUDETTE, Minn., Oct. 25, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2023 financial results on Wednesday, November 8, 2023, prior to the market open. N...

2023-10-18 07:02:30 ET More on ANI Pharmaceuticals ANI Pharma: Slow And Steady Revenue Generator ANI Pharma wins FDA nod for generic Estradiol tablets ANI Pharma granted FDA nod for generic Estradiol Gel For further details see: ANI Pharmaceuticals disclo...